Small-Volume Continuous Manufacturing of Merestinib. Part 1. Process Development and Demonstration-Reference-Cited by-同舟云学术

Small-Volume Continuous Manufacturing of Merestinib. Part 1. Process Development and Demonstration

Published:2019-03-12 Issue:5 Volume:23 Page:858-869
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Cole Kevin P.¹^ORCID,Reizman Brandon J.¹^ORCID,Hess Molly¹,Groh Jennifer M.¹,Laurila Michael E.¹,Cope Richard F.¹,Campbell Bradley M.¹,Forst Mindy B.¹,Burt Justin L.¹,Maloney Todd D.¹,Johnson Martin D.¹,Mitchell David¹^ORCID,Polster Christopher S.¹,Mitra Aurpon W.¹,Boukerche Moussa¹,Conder Edward W.¹,Braden Timothy M.¹,Miller Richard D.¹,Heller Michael R.¹,Phillips Joseph L.¹,Howell John R.¹

Affiliation:

1. Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, Indiana 46285, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.8b00441

Reference28 articles.

1. Economic Analysis of Integrated Continuous and Batch Pharmaceutical Manufacturing: A Case Study

2. Pharmaceutical Roundtable Study Demonstrates the Value of Continuous Manufacturing in the Design of Greener Processes

3. Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality